The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Baricitinib for COVID-19: a suitable treatment?
Open accessAbstract
www.thelancet.com/infection Published online April 3, 2020 https://doi.org/10.1016/S1473-3099(20)30262-0 1 incidence of which might be expected to be higher in immunocompromised patients given JAK inhibitors. In conclusion, we believe that, beyond the intriguing opportunity to directly block the penetration of SARSCoV-2 into the cell, the use of baricitinib in susceptible patients with ongoing pneumonia associated with COVID-19 should be considered with extreme caution.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
COVID-19: combining antiviral and anti-inflammatory treatments
Stebbing, J., Phelan, A., Griffin, I., Tucker, C., Oechsle, O., Smith, D., & Richardson, P. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30132-8 · Cited by 1,117
Cited by
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment
Soy, M., Keser, G., Atagündüz, P., Tabak, F., Atagündüz, I., & Kayhan, S. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05190-5 · Cited by 811
The signal pathways and treatment of cytokine storm in COVID-19
Yang, L., Xie, X., Tu, Z., Fu, J., Xu, D., & Zhou, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00679-0 · Cited by 603
Type I and III interferons disrupt lung epithelial repair during recovery from viral infection
Major, J., Crotta, S., Llorian, M., McCabe, T. M., Gad, H. H., Priestnall, S. L., Hartmann, R., & Wack, A. (2020) · Science · doi:10.1126/science.abc2061 · Cited by 503
Mechanism of baricitinib supports artificial intelligence‐predicted testing in COVID ‐19 patients
Stebbing, J., Krishnan, V., de Bono, S., Ottaviani, S., Casalini, G., Richardson, P. J., Monteil, V., Lauschke, V. M., Mirazimi, A., Youhanna, S., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012697 · Cited by 291
COVID-19 revisiting inflammatory pathways of arthritis
Schett, G., Manger, B., Simon, D., & Caporali, R. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0451-z · Cited by 191
Self-citation
Metadata
- Authors
- Favalli, E. G., Biggioggero, M., Maioli, G., & Caporali, R.
- Venue
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2020-09
- Volume
- 20
- Issue
- 9
- Pages
- 1012-1013
- ISSN
- 1473-3099 (ISSN-L)
- OpenAlex
- W3015018920
- Cited by
- 213
- References
- 1
- FWCI
- 5.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Baricitinib for COVID-19: a suitable treatment? https://app.cochat.ai/papers/10.1016/s1473-3099(20)30262-0
- The paper
- Favalli, E. G., Biggioggero, M., Maioli, G., & Caporali, R. (2020). Baricitinib for COVID-19: a suitable treatment? The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(20)30262-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.